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We investigated if a cancer patient’s unrelieved symptoms during the last 3 months of life increase the risk of long-term
psychological morbidity of the surviving partner. All women (n=506) living in Sweden under 80 years of age, who lost their
husband/partner owing to cancer of the prostate in 1996 or of the urinary bladder in 1995 or 1996 were asked to answer an
anonymous postal questionnaire, 2–4 years after their loss. The widows’ psychological morbidity was associated with the
patient’s unrelieved mental symptoms. When the patient was perceived to have been very anxious during last three months of
life (compared to no observed symptoms) the relative risks for the widows’ psychological morbidity were: 2.5 (1.4–4.3) for
depression and 3.4 (1.4–8.2) for anxiety. When comparing reports of the patient’s pain (much vs no), the relative risks were
0.8 (0.5–1.2) for widowhood depression, and 0.8 (0.4–1.7) for widowhood anxiety. The patients were found to have had
adequate access to physical pain control but poor access to psychological symptom control. Efﬁciency in diagnosing and
treating psychological complications of terminally ill cancer patients may not only improve their quality of life but possibly also
prevent long-term psychological morbidity of their surviving partners.
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Efﬁcient symptom control (physical and psychological) during a
cancer patient’s last months of life is undoubtedly a primary goal
of palliative care. The delay or failure to provide symptom control
results in painful experiences for the patients and their signiﬁcant
others. Moreover, studies have shown that the well-being of patient
and partner is interrelated (Cassileth et al, 1985; Kurz et al, 1995;
Kristjanson et al, 1996; Hodgson et al, 1997). However, it is not
known whether the patient’s unrelieved symptoms result in the
permanent harm of long-term psychological complications of the
surviving partner.
Evidently the loss of a loved life companion from chronic
illness such as cancer induces sorrow that diminishes over time
but may persist for a long time. On top of this, the conditions
before death and the circumstances at the time of death may
include distressing factors that give rise to an extra risk of long-
term psychological morbidity. One such possible distressing factor
that may lead to an avoidable psychological trauma of the surviv-
ing partner is the patient’s suffering (physical or psychological)
before death. Cameron and Parkes (1983) reported that adequate
pain relief of dying patients may contribute to better adjustment
of the bereaved.
Portenoy and Lesage (1999) assess that 70–90% of cancer
patients with advanced disease have chronic pain but that it is
possible that 90% of them could obtain adequate relief. However,
in practice, symptom relief during a cancer patient’s last phase of
life is not always that efﬁcient (Addington-Hall and McCarthy,
1995). Some reasons for inadequate symptom control may be:
insufﬁcient accessibility (distance to health care facilities), a lack
of resources (or knowledge) in health care facilities, an emphasis
on controlling the disease but not the symptoms or a lack of atten-
tion to certain distressing symptoms (e.g. psychological).
Health care should promote well-being, and it is important to
identify if insufﬁcient practice enhances avoidable health problems
among those losing a partner from cancer. In a previous investi-
gation (Ra ˚destad et al, 1996) we found that sub-optimal acts of
care during stillbirth resulted in additional psychological traumata
– increasing the risk of psychological morbidity among the
mothers 3 years after the event. With similar methods as in our
previous investigations (Helgason et al, 1996; Ra ˚destad et al,
1996; Bergmark et al, 1999) we investigated if a cancer patient’s
unrelieved symptoms (physical pain and psychological symptoms)
during the last 3 months of life increased the risk of long-term
psychological complications in the surviving widow. We utilised
the excellent conditions in Sweden, with a unique civil registration
number for all citizens and nearly 100% complete population regis-
ters, to collect information from a large unselected population of
widows who lost their male partner owing to cancer three years
earlier.
MATERIALS AND METHODS
We identiﬁed in the Swedish National Register of Causes of Death
928 men who had died in Sweden of prostate cancer in 1996, and
of urinary bladder cancer in 1995 and 1996. As the questions
concerning the patient’s unrelieved symptoms were asked in a time
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cancer at least 90 days prior to the date of death was required.
The female partners/wives (for simplicity widows) were identiﬁed
in the Swedish Population Register as having had the same address
as the deceased patient at the time of death. Of the 633 women
living with the patients at the time of death, 601 widows were alive
and living in Sweden on the 1st of April 1999. Of these, 35 had
participated in a pilot study, and of the remaining 566, we
attempted to enrol the 506 widows, who were under 80 years of
age, and had a listed telephone number. To establish comparable
population norms for our dependent variables, we randomly chose
one married woman (or a woman living with a man) for every two
widows, matched for age and region of residence, from the Swedish
Population Register. Exclusion was based on the same criteria as in
the widowed population, leaving 287 women in the married popu-
lation.
The widows received an introductory letter explaining the objec-
tives of the study and were then telephoned and asked if they
would participate. Those who agreed were sent a questionnaire
asking about medical care, the patient’s illness and death, and
the widow’s current life situation and well-being. In order to safe-
guard the women’s anonymity, they sent in the questionnaire
separately from an answer card. The study was approved by the
Regional Ethics Committee of the Karolinska Institute.
The questions were developed on the basis of successive in-
depth interviews and tested with face validity. The face validity
procedure was arranged so that the population of widows could
answer the questions appropriately, and that there was a consensus
of understanding and subjective interpretation of the questions
among the widows. The widow’s perception of the patient’s distress
was measured with the following formulations: ‘Did you observe if
pain/anxiety/depression affected your partner’s well-being during
his last 3 months of life?,’ to which there were four possible
answers: ‘No, not at all’, ‘Yes, a little’, ‘Yes, moderately’, and
‘Yes, a lot’. The questions concerning the patient’s access to pain
control had the following multiple choice answers: ‘My partner
did not have any need for pain control’, ‘No, access’, ‘Little access’,
‘Moderate access’, and ‘Much access’. Access to psychological
support was asked about in a similar manner. The widows’ (and
the married women’s) anxiety, depression, physical health, psycho-
logical well-being and quality of life were measured on a seven
point visual digital scale using the following formulations: ‘Have
you been anxious/depressed during the past week?’ (ranging from
‘Never’ to ‘All the time’), ‘How would you rate your current physi-
cal health/psychological well-being/quality of life? (ranging from
‘very bad’ to ‘very good’ or ‘worst possible quality of life’ to ‘best
possible quality of life’. The respondents were asked about sleep
disturbances and intake of sleeping pills and tranquillisers during
the previous month and the possible answers were: ‘No, never’,
‘Yes, once or twice’, ‘Yes, a few times (1–2 times per week)’,
‘Yes, several times (about 3–4 times per week)’ or ‘Yes, nearly
always or every day/night’. Two summarising scales were used:
Spielberger’s Trait measure from the State–Trait Anxiety Inventory
(Spielberger et al, 1983), and the Centre for Epidemiological
Studies (CES-D) measure of depression (Radloff, 1994).
The responses to the questionnaire have been dichotomised, and
the results are presented as relative risks; calculated as the propor-
tion of widows with a particular problem who reported high levels
of unrelieved symptoms of the deceased divided by the proportion
of widows reporting low levels of unrelieved symptoms. Cut-off
points correspond to our prior work (Helgason et al, 1996; Ra ˚des-
tad et al, 1996; Bergmark et al, 1999) and were chosen to meet the
criteria of clinical signiﬁcance.
Using the Mantel–Haenszel method (Rothman and Greenland,
1998), estimated relative risks were adjusted for possible confound-
ing factors that have been identiﬁed as risk factors of psychological
morbidity. These comprise: the women’s age (Ball, 1977); marital
status and educational level (Ra ˚destad et al, 1996); emotional rela-
tions/support (Kurz et al, 1997); the women’s participation in the
care of her partner (Ha ¨ggmark et al, 1991); intensity of religious
faith; treatment for mental health problems prior to the disease/
loss; the site and duration of the patient’s illness; and the duration
of time the woman was aware of her partner’s impending death
(awareness time) (identiﬁed in this data set).
RESULTS
Information was supplied by 379 (75%) of the 506 widows. On the
average, 3 years had elapsed between the death of the patient and
the point in time of the follow-up. The follow-up time (the time
since the patient died being 2–3 years compared with 3–4 years)
was not associated with reports of the patient’s unrelieved symp-
toms – (RR=1.0 (0.9–1.2) for patient’s depression, RR=0.9
(0.8–1.1) for patient’s anxiety, RR=1.1 (1.0–1.2) for patient’s
pain). Table 1 shows the widows’ (and the married women’s)
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Table 1 Characteristics of the women who had lost their husbands/part-
ners to prostate and urinary bladder cancer and the controls
Characteristics
Surviving
widows
Married
women*
Number identiﬁed in registries 506 287
Reasons for nonparticipation–No. (%)
Refused/no given reason 36 (7) 23 (8)
Psyhological burden 34 (7) 5 (2)
Illness 13 (3) 4 (1)
Said yes, but did not return questionnaire 25 (5) 18 (6)
Not reachable 10 (2) 5 (2)
Deceased 1 (51) 3 (1)
Unknown or other reasons 8 (2) 9 (3)
Total nonparticipation–No. (%) 127 (25) 67 (23)
Answered questionnaire–No. (%) 379 (75) 220 (77)
Age–No. (%)
40–49 years 3 (1) 6 (2)
50–59 years 48 (13) 32 (15)
60–69 years 154 (41) 78 (34)
70–79 years 167 (44) 103 (48)
Not indicated 7 (2) 1 (51)
Age at time of study–mean (s.e.) 67.6 (0.34) 67.5 (0.51)
Time elapsed from death to follow-up–
mean (range)
3.04 (1.95) —
Marital status–No. (%)
Married or living with a man 7 (2) 219 (100)
Has a partner but lives alone 22 (6) —
Single 345 (91) —
Not indicated 5 (2) 1 (51)
Level of education–No. (%)
Primary school 224 (59) 129 (59)
Secondary school 92 (24) 50 (23)
University 51 (13) 37 (17)
Not indicated 12 (3) 4 (2)
Employment status–No. (%)
Employed 79 (21) 45 (20)
On sick leave 21 (6) 8 (4)
Unemployed 5 (1) 4 (2)
Retired 269 (71) 157 (71)
Other 3 (1) 6 (3)
Not indicated 2 (51) —
Region of residence–No. (%)
Rural area 63 (16) 37 (17)
Small town 102 (27) 67 (31)
City 154 (41) 80 (36)
Large city (4500 000 inh.) 57 (15) 35 (16)
Not indicated 3 (1) 1 (51)
*Women who are either married or living with a man.
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ã 2002 Cancer Research UK British Journal of Cancer (2002) 86(10), 1540–1545age distribution, marital status, residence region, level of education
and employment status.
The patient’s mental health status during the last 3 months
of life was predictive of the widows’ anxiety and depression
levels as well as sleep disturbances at the time of follow-up
(Tables 2 and 3). When the patient was perceived as being very
anxious (compared to no observed symptoms) the relative risks
for the widow’s psychological symptoms were (adjusted for
awareness time): 3.6 (1.5–9.4) for anxiety and 2.6 (1.5–4.4)
for depression (3-7/7 on the visual digital scales), 3.1 (0.7–
13.0) for anxiety related symptoms (above the 90th percentile
on STAI-T), 3.4 (0.9–13.6) for depression related symptoms
(above the 90th percentile on CES-D), 1.8 (1.2–2.6) for difﬁ-
culty in falling asleep at night and 2.5 (1.1–5.5) for waking
up at night with anxiety. Similar increases in the widow’s risk
of psychological complications were obtained when the patient
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Table 2 Mental morbidity of the widows with varying reports of their partner’s anxiety during the last 3 months of life
Married women
Patient’s distress owing to anxiety
Variables (n=220) None A Little Moderate Much
1. Reported anxiety–No./total No. (%) 32/215 (15) 5/53 (9) 20/79 (25) 31/96 (32) 39/121 (32)
RR little/mod/much patient anxiety vs no anxiety. (CI) — 1.0 2.7 (1.1–3.4) 3.4 (1.4–8.3) 3.4 (1.4–8.2)
2. Anxiety-related symptoms–No./total No. (%)
(above the TRAIT 90th percentile) 7/213 (3) 2/51 (4) 8/75 (11) 10/94 (11) 12/111 (11)
RR little/mod/much patient anxiety vs no anxiety. (CI) — 1.0 2.7 (0.6–12.3) 2.7 (0.6–11.9) 2.8 (0.6–11.9)
3. Reported depression– No./total No. (%) 46/216 (21) 11/53 (21) 29/78 (37) 58/98 (59) 62/120 (52)
RR little/mod/much patient anxiety vs no anxiety. (CI) — 1.0 1.8 (1.0–3.3) 2.9 (1.6–4.9) 2.5 (1.4–4.3)
4. Depression-related symptoms–No./total No. (%)
(above the CES-D 90th percentile) 11/188 (6) 2/50 (4) 7/69 (10) 8/90 (9) 15/104 (14)
RR little/mod/much patient anxiety vs no anxiety. (CI) — 1.0 2.5 (0.6–11.7) 2.2 (0.5–10.1) 3.6 (0.9–15.2)
5. Intake of tranquillisers
(at least 1–26 per week)–No./total No. (%) 15/219 (7) 5/55 (9) 8/79 (10) 11/98 (11) 9/121 (7)
RR little/mod/much patient anxiety vs no anxiety. (CI) — 1.0 1.1 (0.4–3.6) 1.2 (0.5–3.4) 0.8 (0.3–2.3)
6. Difﬁculty falling asleep at night
(at least 1–26 per week)–No./total No. (%) 56/216 (26) 19/54 (35) 32/79 (41) 49/99 (50) 74/122 (61)
RR little/mod/much patient anxiety vs no anxiety. (CI) — 1.0 1.2 (0.7–1.8) 1.4 (0.9–2.1) 1.7 (1.2–2.5)
7. Waking up at night with anxiety
(at least 1–26 per week)–No./total No. (%) 25/215 (12) 6/53 (11) 19/80 (24) 24/99 (24) 34/122 (28)
RR little/mod/much patient anxiety vs no anxiety. (CI) — 1.0 2.1 (0.9–4.9) 2.1 (0.9–4.9) 2.5 (1.1–5.5)
8. Intake of sleeping pills
(at least 1–26 per week)–No./total No. (%) 22/216 (10) 8/56 (14) 9/81 (11) 21/99 (21) 27/122 (22)
RR little/mod/much patient anxiety vs no anxiety. (CI) — 1.0 0.8 (0.3–1.9) 1.5 (0.7–3.1) 1.5 (0.8–3.2)
Table 3 Mental morbidity of the widows with varying reports of their partner’s depression during the last 3 months of life
Married women
Patient’s distress owing to depression
Variables (n=220) None A Little Moderate Much
1. Reported anxiety–No./total No. 32/215 (15) 5/32 (16) 17/89 (19) 34/104 (33) 39/128 (31)
RR little/mod/much patient depression vs no depression. (CI) — 1.0 1.2 (0.5–3.0) 2.1 (0.9–4.9) 2.0 (0.8–4.5)
2. Anxiety-related symptoms–No./total No. (%)
(above the TRAIT 90th percentile) 7/213 (3) 1/27 (4) 6/77 (7) 12/107 (11) 13/119 (11)
RR little/mod/much patient depression vs no depression. (CI) — 1.0 2.1 (0.3–16.7) 3.0 (0.4–22.3) 3.0 (0.4–21.6)
3. Reported depression– No./total No. (%) 46/216 (21) 6/31 (19) 30/89 (34) 64/108 (59) 64/126 (51)
RR little/mod/much patient depression vs no depression. (CI) — 1.0 1.7 (0.8–3.8) 3.1 (1.5–6.5) 2.6 (1.3–5.5)
4. Depression-related symptoms–No./total No. (%)
(above the CES-D 90th percentile) 11/188 (6) 1/25 (4) 4/80 (5) 9/100 (9) 18/112 (16)
RR little/mod/much patient depression vs no depression. (CI) — 1.0 1.3 (0.1–10.7) 2.3 (0.3–17.0) 4.0 (0.6–28.7)
5. Intake of tranquillisers
(at least 1–26 per week)–No./total No. (%) 15/219 (7) 1/32 (3) 8/88 (9) 12/109 (11) 10/128 (8)
RR little/mod/much patient depression vs no depression. (CI) — 1.0 2.9 (0.4–22.4) 3.5 (0.5–26.1) 2.5 (0.3–18.8)
6. Difﬁculty falling asleep at night
(at least 1–26 per week)–No./total No. (%) 56/216 (26) 12/33 (36) 36/89 (40) 52/108 (48) 75/129 (58)
RR little/mod/much patient depression vs no depression. (CI) — 1.0 1.2 (0.7–1.7) 1.3 (0.8–2.2) 1.6 (1.0–2.6)
7. Waking up at night with anxiety
(at least 1–26 per week)–No./total No. (%) 25/215 (12) 4/30 (13) 14/90 (16) 26/110 (24) 38/129 (30)
RR little/mod/much patient depression vs no depression. (CI) — 1.0 1.2 (0.4–3.3) 1.8 (0.7–4.7) 2.2 (0.9–5.7)
8. Intake of sleeping pills
(at least 1–26 per week)–No./total No. (%) 22/216 (10) 4/33 (12) 11/91 (11) 26/110 (24) 23/129 (18)
RR little/mod/much patient depression vs no depression. (CI) — 1.0 1.0 (0.3–2.9) 2.0 (0.7–5.2) 1.5 (0.5–4.0)
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British Journal of Cancer (2002) 86(10), 1540–1545 ã 2002 Cancer Research UKwas considered to have been very depressed during his last
months of life.
Reports of the patient’s distress owing to pain were not asso-
ciated with the widow’s mental health at follow-up (Table 4).
When the patient was in much pain (compared to no observed
symptoms) the relative risks for widows’ psychological complica-
tions were (adjusted for awareness time): 0.9 (0.4–1.9) for
anxiety and 0.8 (0.5–1.3) for depression (3-7/7 on the visual digi-
tal scales).
We examined additional variables, and found, just as for pain,
no relation to the widow’s mental health at follow-up (not in
table). The relative risks for the widows’ depression (visual digital
scale) were: 1.0 (0.8–1.1) for when the patients had had much
symptoms in the urinary tract (compared to no observed symp-
toms), 1.0 (0.7–1.5) for oedema, 1.0 (0.8–1.1) for constipation,
1.0 (0.7–1.4) for vomiting, and 1.1 (0.8–1.4) for disrupted sleep
owing to urinary tract symptoms.
Sixty-six per cent (242 out of 366) of the patients were assessed
to have been moderately or much depressed during the last 3
months of life, 62% (222 out of 360) as anxious and 87% (309
out of 357) in pain. A considerable difference was noted in access
to pain control and psychological support. While a small minority
of the women stated that their husbands had not needed the
services; of the remaining majority 93% had moderate or much
access to pain control during the last 3 months of life compared
to only 33% regarding psychological support (Table 5).
Stratum speciﬁc and adjusted relative risks were calculated by
the Mantel–Haenszel method (data not shown). The relationship
between the patient’s anxiety and the widow’s depression is
slightly weakened when controlled for treatment for mental
health problems before the patient’s illness; however, this group
of treated women is very small and the relationship is intact
for the others. The relative risks increase somewhat after adjust-
ing for the widow’s awareness time, i.e. the time the woman was
aware of her partner’s impending death. Marital status shows
tendency to modify (not signiﬁcantly) – the relationship is
hardly apparent among widows who have remarried or have a
subsequent relationship.
DISCUSSION
Inefﬁcient psychological symptom control during the last months
of a cancer patient’s life may predispose the surviving partner to
long-term psychological morbidity. The widows assessed that the
patients had good access to pain control, but poor access to
psychological support.
To our knowledge, our study is the ﬁrst investigating the rela-
tionship between the patient’s psychological condition during the
last months of life and psychological morbidity in surviving partner
3 years later. This fact, and validity issues inherent in our observa-
tional design, hinders a deﬁnite conclusion concerning causality.
Several previous studies give indirect support for our ﬁndings. It
has been reported that the well-being of cancer patients and their
family caregivers is interrelated during the illness (Cassileth et al,
1985; Kurz et al, 1995; Kristjanson et al, 1996; Hodgson et al,
1997) and others have found the mental condition of the well part-
ner during the terminal period to be the main risk factor of
morbidity in widowhood (Kelly et al, 1999). We have no indication
of that validity problems explain our ﬁndings. One evident validity
concern is if women with psychological complications have a
general tendency to over-report unrelieved symptoms of their
husband. We found that the patient’s unrelieved pain, symptoms
of the urinary tract, oedema, constipation, vomiting and disrupted
sleep owing to urinary tract symptoms, gave relative risks for the
widows anxiety and depression close to 1.0, indicating that a gener-
al over-reporting cannot explain our ﬁndings (further validity
discussion is given below). The differences in access to physical
pain relief and psychological symptom relief (support/drugs) offers
a probable explanation for the differential effects on the women’s
psychological morbidity.
A mechanism explaining the relationship between the patient’s
psychological symptoms and the widow’s depression 3 years later
may be ‘learned helplessness’. The woman was not able to help
her partner/husband with his anxiety or depression, nor did the
health care professionals ameliorate the symptoms. She was thus
exposed to chronic distressing stimuli from which she could not
escape – a situation that may give rise to a feeling of helplessness
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Table 4 Mental morbidity of the widows with varying reports of their partner’s pain during the last 3 months of life
Married women
Patient’s distress owing to pain
Variables (n=220) None A Little Moderate Much
1. Reported anxiety–No./total No. 32/215 (15) 5/15 (33) 9/33 (27) 25/85 (29) 55/210 (26)
RR little/mod/much patient pain vs no pain. (CI) — 1.0 0.8 (0.3–2.0) 0.9 (0.4–1.9) 0.8 (0.4–1.7)
2. Anxiety-related symptoms–No./total No. (%)
(above the TRAIT 90th percentile) 7/213 (3) 2/15 (13) 2/33 (6) 11/79 (14) 16/198 (8)
RR little/mod/much patient pain vs no pain. (CI) — 1.0 0.5 (0.1–2.9) 1.0 (0.3–4.2) 0.6 (0.2–2.4)
3. Reported depression– No./total No. (%) 46/216 (21) 9/15 (60) 13/32 (41) 43/85 (51) 97/212 (46)
RR little/mod/much patient pain vs no pain. (CI) — 1.0 0.7 (0.4–1.2) 0.8 (0.5–1.3) 0.8 (0.5–1.2)
4. Depression-related symptoms–No./total No. (%)
(above the CES-D 90th percentile) 11/188 (6) 3/14 (21) 4/32 (13) 6/79 (8) 18/185 (10)
RR little/mod/much patient pain vs no pain.(CI) — 1.0 0.6 (0.2–2.3) 0.4 (0.1–1.3) 0.5 (0.2–1.4)
5. Intake of tranquillisers
(at least 1–26 per week)–No./total No. (%) 15/219 (7) 3/15 (20) 0/33 (0) 9/88 (10) 18/213 (9)
RR little/mod/much patient pain vs no pain. (CI) — 1.0 — 0.5 (0.2–1.7) 0.4 (0.1–1.3)
6. Difﬁculty falling asleep at night
(at least 1–26 per week)–No./total No. (%) 56/216 (26) 9/14 (64) 14/33 (42) 46/87 (53) 102/215 (47)
RR little/mod/much patient pain vs no pain. (CI) — 1.0 0.7 (0.4–1.2) 0.8 (0.5–1.3) 0.7 (0.5–1.1)
7. Waking up at night with anxiety
(at least 1–26 per week)–No./total No. (%) 25/215 (12) 6/15 (40) 6/33 (18) 24/86 (28) 45/215 (21)
RR little/mod/much patient pain vs no pain. (CI) — 1.0 0.5 (0.2–1.2) 0.7 (0.3–1.4) 0.5 (0.3–1.0)
8. Intake of sleeping pills
(at least 1–26 per week)–No./total No. (%) 22/216 (10) 4/15 (27) 5/33 (15) 9/88 (10) 42/218 (19)
RR little/mod/much patient pain vs no pain. (CI) — 1.0 0.6 (0.2–1.8) 0.4 (0.1–1.1) 0.7 (0.3–1.7)
Symptom control and morbidity in widowhood
U Valdimarsdo ￿ttir et al
1543
ã 2002 Cancer Research UK British Journal of Cancer (2002) 86(10), 1540–1545or a hopeless expectation towards life. Exposure to inescapable,
distressing stimuli has been associated with a response of helpless-
ness in animals – a behaviour that resembles human depression
(Seligman, 1974). Using a role playing technique (‘empty chair
method’), 73 bereaved spouses (for 6 months) were given a last
opportunity to talk with their deceased spouse. Levels of unresolved
grief during the role playing session (e.g., anger, guilt, helplessness,
non-acceptance) predicted levels of depression (Beck’s Depression
Inventory) and subjective distress (Impact of Event Scale) 8 months
later (Field and Horowitz, 1998). Moreover, uncontrollable events
predicted higher depression levels among caregiving spouses of
Alzheimer patients (Pagel et al, 1985), possibly mediated though
the mechanism of learned helplessness.
Intrusive, painful memories of the patient’s mental suffering and
avoidance of stimuli that trigger these, may explain the increased
percentage of women reporting anxiety and anxiety related symp-
toms (e.g., STAI-T and sleep disturbances). It is possible that our
documentation of the increased risk of anxiety after the exposure
to patient’s unrelieved symptoms may partly resemble a Post-trau-
matic Stress Disorder. The condition has previously been reported
after a loss of a partner of chronic illness (Zisook et al, 1998).
Contrary to expectations, the widow’s long-term psychological
morbidity was not associated with the widow’s evaluation of the
degree of pain experienced by her late partner. It is possible that
our question of somatic pain was too crude, and that a more sensi-
tive measure is needed to investigate the relationship. It is also
possible that the woman did not feel responsible for relieving the
patient’s physical pain and therefore did not acquire a feeling of
helplessness or guilt leading to subsequent mental health symptoms.
Furthermore, access to pain relief was satisfactory, so, even if the
patient experienced pain, efforts were made to relieve it so the
situation may not have been perceived as ‘uncontrollable’ at all.
Moreover, the woman may have been able to make an effort – call
for help, or deliver morphine as prescribed.
The widows’ reports clearly illustrate current possibilities in
Sweden to improve the mental health condition of terminally ill
cancer patients. About two thirds of the patients are judged to have
been moderately or highly anxious/depressed during their last 3
months of life, while only 29% of these had satisfactory access to
psychological support and only about 50% of them were given
psychoactive drugs. Previous research from England (Fallowﬁeld
et al, 2001) and Austria (Sollner et al, 2001) indicates that physi-
cians caring for cancer patients may be poor at identifying
psychological symptoms among their patients.
Our study is observational, and thus has a large number of
validity concerns that have been addressed in the design, execution
and analysis (Steineck et al, 1998). Our population based registers,
from which we were able to retrieve a non-selected nationwide
cohort of widows, diminish problems pertaining to selection and
give us full control over the denominator in calculating the parti-
cipation rate. In order to disentangle the effect of possible
predictors from other aspects related to the speciﬁc disease site,
we decided to have as homogenous a group as possible and only
include women who’s husband/partner had died owing to these
two cancer sites. However, we needed these two kinds of cancer
sites in order to get a large enough number for the statistical analy-
sis. Based on our previous investigations, we expected the response
rate to be low for women 80 years and older. We excluded them
from the study, both for their sake (too much work load) and
for the sake of validity. The follow-up time interval was a compro-
mise between the objective of investigating long-term morbidity
and the women’s possible memory capacity. In preparatory inter-
views, we studied the time interval that could possibly elapse
between the loss and follow-up, in order for the women to be able
to recall the event and answer the questions. Furthermore, addi-
tional analysis of our material revealed that the follow-up time
(being 2–3 years or 3–4 years) did not matter for the widows’
evaluation of the patients’ unrelieved symptoms. The questionnaire
was designed to collect information on a number of potential
confounders. The association between the patient’s anxiety and
the widow’s risk of depression was weaker among women treated
for mental health problems prior to the partner’s illness, compared
to other women. The relative risks change somewhat after adjust-
ment for this variable but the subgroup is too small and the
relationship is intact for widows that have not been treated for
mental health problems. The relative risks change little, if at all,
on adjusting for the remaining potential confounding factors, indi-
cating that confounding owing to these factors cannot explain our
ﬁndings.
We have used established scales for measuring anxiety related
symptoms (STAI-T) and depression related symptoms (CES-D),
and added clear direct questions (tested by face validity and
previous investigations) (Helgason et al, 1996; Ra ˚destad et al,
1996; Bergmark et al, 1999) pertaining to anxiety, depression,
and consumption of tranquillising drugs. Our questions about
the patient’s condition were tested by face validity and in prepara-
tory studies. Furthermore, in the analysis of our data we
contemplated whether women with psychological complications
had a general tendency to over-report the unrelieved symptoms
of their husbands/partners. We found no indication of such differ-
ential reporting to explain our ﬁndings.
To sum up, our ﬁndings imply that unrelieved psychological
symptoms of terminally ill cancer patient’s increase the risk of
long-term psychological morbidity of their surviving widows. Efﬁ-
ciency in diagnosing and treating psychological complications of
terminally ill cancer patient’s may not only improve their quality
of life but possibly also prevent long-term psychological morbidity
of their surviving partners.
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